Dormant
AGYS · Agilysys, Inc.
Last analysed ·
Resolved Graded and closed 2026-07-22 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.
Current thesis
Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that houses the documented lumpy-bookings risk. Narrative intact but stretched — extension into an event rather than a fresh base.
Kill line
A daily close below $98 (loses the rising 20-EMA that guided the July run off the ~$92 base); confirmed by a weekly close below $88 (June higher-low breakout shelf fails), or a 2026-07-27 Q1 print that cuts the >30% subscription-growth framing or brings revenue below double-digit YoY growth off the ~$74M Q1 FY2026 base.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for AGYS —
As of 19 September 2026, the latest FrontierPicks analysis for Agilysys, Inc. (AGYS): Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that houses the documented lumpy-bookings risk. Narrative intact but stretched — extension into an event rather than a fresh base.
Kill line: A daily close below $98 (loses the rising 20-EMA that guided the July run off the ~$92 base); confirmed by a weekly close below $88 (June higher-low breakout shelf fails), or a 2026-07-27 Q1 print that cuts the >30% subscription-growth framing or brings revenue below double-digit YoY growth off the ~$74M Q1 FY2026 base.
Current Thesis
Agilysys’s subscription-conversion recovery depends on its next quarterly results confirming faster subscription growth and retaining the raised annual outlook before the market loses the published $98 research boundary. The measurable confirmation case is fiscal Q2 subscription growth of at least 30%, with the FY2027 revenue and subscription-growth guidance issued on 2026-07-27 retained. This is a research condition, not company guidance for an exact quarterly outcome.
The September deterioration has extended: the adjusted market close was $100.13 on 2026-09-18, compared with $111.36 on 2026-09-04 in the previous published note. The narrative is maturing — the 2026-07-27 guidance increase remains its operating anchor, while the September price observations show weaker market support. That classification is an inference from operating disclosures and price, not a measurement of investor flows.
The July results establish the operating case: fiscal Q1 revenue reached $87.7 million, up 14.3% year over year, and recurring revenue represented 65.9% of sales. Management raised FY2027 revenue guidance to $368–373 million and subscription-growth guidance to at least 32%. Agilysys release, 2026-07-27
Bullish and bearish views on Agilysys, Inc.
The model's bull view on Agilysys, Inc. (AGYS), in brief: Subscription conversion has measurable scale. The bear view: Annual acceleration remains unproved. Fiscal Q1 subscription growth was 26.1%, below management’s at-least-32% full-year outlook issued on 2026-07-27. The inference is that subsequent quarters must accelerate; the guidance increase itself does not establish that acceleration.… Both cases follow in full.
Bull Case
- Subscription conversion has measurable scale. Recurring revenue reached $57.7 million in fiscal Q1, compared with $48.6 million a year earlier, according to the 2026-07-27 release. Its increasing contribution supports the legacy-software conversion thesis. Company results
- Property management supplies the acceleration. On the 2026-07-27 call, management reported 39.7% subscription growth in property management systems (PMS) and related modules; PMS subscription revenue exceeded point-of-sale subscription revenue for the first time. Earnings-call transcript
- Management specified the next test. Chief Financial Officer Dave Wood said on 2026-07-27 that fiscal Q2 subscription growth should approach 30%, followed by acceleration in subsequent quarters. This supplies a checkable management expectation for the next report. Earnings-call transcript
Bear Case
- Annual acceleration remains unproved. Fiscal Q1 subscription growth was 26.1%, below management’s at-least-32% full-year outlook issued on 2026-07-27. The inference is that subsequent quarters must accelerate; the guidance increase itself does not establish that acceleration. Company results
- September price support has weakened. The 2026-09-18 adjusted close of $100.13 was below the previously published 2026-09-04 close of $111.36. Those observations establish deterioration between reference dates, but do not establish the intervening daily path.
- Insider transactions require separate interpretations. The August Form 4 disclosures recorded chief executive sales during 2026-08-05 through 2026-08-07. The Form 4 filed on 2026-09-02 identified the commercial chief’s 2026-09-01 transaction as tax withholding related to vesting. These are observable supply events, not evidence that insiders anticipated weaker results.
Setup & Price Structure
At the 2026-09-18 adjusted close, AGYS was 29.0% below its $141.12 annual high while retaining an 18.6% three-month price increase. Its 14-day relative strength index (RSI) was 22.2. These supplied observations describe recent weakness within a positive three-month move; they do not establish a reversal.
The $98 boundary remains the research invalidation level identified in the earlier published note. A current moving-average value is unavailable, so $98 cannot be described as today’s 20-day exponential moving average. The available closing observations also cannot establish whether an intervening session already breached that boundary.
Positioning evidence is limited to the dated insider disclosures and analyst coverage. MarketBeat’s 2026-09-10 snapshot still listed Needham’s 2026-08-10 increase to $135 as its latest target change. That limited record does not establish a current consensus across providers, retail crowding or renewed demand. MarketBeat analyst history
Catalyst Calendar (next 30 days)
- 2026-09-30 — fiscal Q2 quarter end. This closes the reporting period that tests the acceleration discussed on the 2026-07-27 call. Quarter end is an accounting milestone; no accompanying results release has been verified.
- ~2026-10-26, estimated — fiscal Q2 results. Beyond the next 30 days, MarketBeat estimates this reporting date from historical schedules. Company confirmation remains unavailable; the event matters because it reports subscription growth and updates annual guidance. MarketBeat earnings calendar
No company-confirmed operating disclosure within the next 30 days was identified as of 2026-09-20.
What Would Change Our Mind
Loss of the previously published market boundary ends the recovery setup: a daily close below $98 is the price invalidation. A reduction in the at-least-32% FY2027 subscription-growth outlook issued on 2026-07-27 separately breaks the acceleration premise.
Confirmation requires the next quarterly report to meet the subscription-growth and retained-guidance conditions stated above before price invalidation. Conviction remains low because the 2026-09-18 price evidence has weakened while that operating test remains unresolved.
Correlation Notes
This is a single-company setup as of 2026-09-20. No matched peer-return series or measured correlation accompanies the 2026-09-18 price observations, so they cannot distinguish company-specific weakness from a broader software decline. The 2026-07-27 subscription disclosure supports a hospitality-software conversion thesis; it does not establish that artificial-intelligence sector flows explain AGYS’s price changes.
Notes
- Fiscal year ends March 31: Q2 FY2027 covers the quarter ending 2026-09-30 and has historically been reported in late October; the date has not been announced.
- Headline EPS is adjusted. Q1 FY2027 adjusted diluted EPS was $0.49 against GAAP diluted $0.32 — beat comparisons only hold like-for-like.
- 28,205,788 shares outstanding per the August 2026 Form 144. A small count, so single-holder sales and index flows move price more than a market-cap screen implies.
- Part of insider supply is compensation-derived: the 2026-09-01 sale was footnoted as sell-to-cover for restricted-stock withholding, so some Form 4s recur on a vesting schedule.
- The Marriott PMS rollout signed in December 2022 is multi-year and back-end loaded; management has warned against expecting an even quarterly rollout cadence.
- One-time product revenue is the historical break point: on 2026-01-21 revenue of $69.6M against $73.1M expected plus a guide cut took shares down roughly 25% intraday.
Related · shared themes
APPN
Appian Corporation
Appian’s AI orchestration re-rating needs Q3 revenue of at least $214 million and cloud subscriptions of at least $133 million to confirm management’s August guidance. A weekly close below $34 or a miss against either revenue floor invalidates the case.
CRM
Salesforce, Inc.
De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions between 2026-08-12 and 2026-08-20 chased price to $209.17; the 2026-08-26 Q2 FY27 print is the binary and much of the discount closed before it.
CRWD
CrowdStrike Holdings, Inc.
Fal.Con (2026-08-31 to 09-03) delivered real product — Falcon Guardian, Falcon IQ, GPT-5.6 Cyber in Falcon, Anthropic marketplace distribution — and nine broker actions through 2026-09-04 including Truist $300, yet CRWD closed $213.10 on 2026-09-04, below the $218.40 of 08-28 and the $233.88 range high. The catalyst is spent and no company-dated event lands before the ~2026-12-02 Q3 print, leaving a maturing narrative carried by targets rather than a widening bid.
FROG
JFrog Ltd.
Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June. Fundamentals accelerating (Q1 rev +26%, security 10% of ARR), but a fresh long is extended near 52-week highs with the ~Aug 6 Q2 print the next binary.